Consequently, we might suggest different roles for GFAP and NfL, with GFAP being more informative in the earlies stages of the disease and NfL being more useful in monitoring the progression of Alzheimer's pathological changes to Alzheimer's disease. The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.